Emcitate
Tiratricol
RARE THYROID THERAPEUTICS INTERNATIONAL AB · Oral Tablet
Spring Bio Solution provides end-to-end comparator drug sourcing services for pharmaceutical companies and Contract Research Organizations (CROs).
We offer seamless comparator sourcing in compliance with global regulatory standards. The clinical trial supplies that we provide are sourced from approved, audited, and regulatory-compliant suppliers. Thanks to the extensive global network that we have, it enables effortless access to comparators across multiple international markets.
Tiratricol
RARE THYROID THERAPEUTICS INTERNATIONAL AB · Oral Tablet
Zilurgisertib
INCYTE CORP · Oral Tablet
Tavapadon
ABBVIE INC · Oral Tablet
Lirafugratinib
ELEVAR THERAPEUTICS INC · Oral Capsule
Insulin Efsitora Alfa-Gobe
ELI LILLY AND CO · Subcutaneous Injectable
Floretyrosine F 18
TELIX PHARMACEUTICALS US INC · Intravenous Solution
Apitegromab-Mstn
SCHOLAR ROCK INC · Injectable Injection
Camizestrant
ASTRAZENECA PHARMACEUTICALS LP · Oral Tablet
Zilganersen
IONIS PHARMACEUTICALS INC · Intrathecal Solution
Rusfertide Acetate
TAKEDA PHARMACEUTICALS U.S.A., INC. · Subcutaneous Powder
Brepocitinib
PRIOVANT THERAPEUTICS INC · Oral Tablet
Daraxonrasib
REVOLUTION MEDICINES INC · Oral Tablet
Garetosmab-grts
REGENERON PHARMACEUTICALS, INC · Intravenous Injectable
Iberdomide Hydrochloride
BRISTOL MYERS SQUIBB CO · Oral Capsule
Florquinitau F 18
CERVEAU TECHNOLOGIES INC A LANTHEUS CO · Intravenous Solution
Oveporexton
TAKEDA PHARMS USA · Oral Tablet
Centanafadine
OTSUKA PHARMACEUTICAL · NA
Bevacizumab-vikg
OUTLOOK THERAPEUTICS, INC. · Single-dose Vial
Zidesamtinib
NUVALENT INC · Oral Tablet
Enlicitide Decanoate
MERCK SHARP AND DOHME LLC · Oral Tablet

Reliable sourcing solution to maintain clinical trial timelines

Competitive pricing without compromising quality or compliance

Customized service with a dedicated team to manage your requirements

Temperature-controlled and secure delivery of clinical trial supplies
Fill out the form below, and we will be in touch shortly.